Rapport Therapeutics | SC 13G:超过5%持股股东披露文件-ARCH Venture Fund XII, L.P.(10.2%),ARCH Venture Partners XII, L.P.(10.2%)等
Rapport Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Asset Management, LP(8.04%),Bihua Chen(8.04%)
Rapport Therapeutics | SC 13G:超过5%持股股东披露文件-Capital International Investors(7.1%)
Rapport Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)
Rapport Therapeutics | 4:持股变动声明-董事 Young Wendy B.
Rapport Therapeutics | 4:持股变动声明-董事 PEREZ ROBERT J
Rapport Therapeutics | 4:持股变动声明-董事 Silva Paul M
Rapport Therapeutics | 4:持股变动声明-董事 Sanchez Ramiro
Rapport Therapeutics | 3:首次持股声明-董事 PEREZ ROBERT J
Rapport Therapeutics | 3:首次持股声明-董事 Silva Paul M
Rapport Therapeutics | 3:首次持股声明-董事 Sanchez Ramiro
Rapport Therapeutics | 3:首次持股声明-董事 Young Wendy B.
Rapport Therapeutics | SC 13G:超过5%持股股东披露文件-Johnson & Johnson(6.8%),Johnson & Johnson Innovation-JJDC, Inc.(6.8%)
Rapport Therapeutics | SC 13G:超过5%持股股东披露文件-FMR LLC(13.624%),Abigail P. Johnson(13.624%)
Rapport Therapeutics | 4:持股变动声明-董事 HEALY JAMES
Rapport Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-THE GOLDMAN SACHS GROUP, INC.(3.5 %),GOLDMAN SACHS & CO. LLC(3.5 %)等
Rapport Therapeutics | SC 13G:超过5%持股股东披露文件-THE GOLDMAN SACHS GROUP, INC.(7.5 %),GOLDMAN SACHS & CO. LLC(7.5 %)等
Rapport Therapeutics | SC 13G:超过5%持股股东披露文件-Cormorant Asset Management, LP(8.04%),Bihua Chen(8.04%)等
Rapport Therapeutics | SC 13D:超过5%持股股东披露文件-Dr. James I. Healy (“Healy”)(5.5%),Sofinnova Venture Partners XI, L.P. (“SVP XI”)(5.3%)等
Rapport Therapeutics | 4:持股变动声明-股东 ARCH Venture Partners XII, LLC